The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / April / Endometriosis Blood Test An End to Years of Agony
Liquid biopsy Microbiology and Immunology Molecular Pathology Research and Innovations

Endometriosis Blood Test: An End to Years of Agony?

Multi-omic assay could reduce reliance on surgery and imaging

04/09/2026 News 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll

Share

Objective:

To evaluate a multi-marker blood test for the accurate detection of endometriosis and its potential to identify cases missed by standard imaging.

Approach:
    Key Findings:
    • The blood test identified many histologically confirmed cases missed by ultrasound or MRI.
    • It maintained consistent performance across different phases of the menstrual cycle.
    • The assay integrates multiple biological processes reflecting the systemic nature of endometriosis.
    Interpretation:

    The findings suggest that a blood-based diagnostic approach could significantly reduce the time to diagnosis and reliance on invasive procedures, enabling earlier intervention for symptomatic patients.

    Limitations:
    • Further validation in larger and more diverse populations is necessary.
    Conclusion:

    The study highlights the potential of integrated biomarker panels to enhance diagnostic accuracy and improve endometriosis care.

    Sources:
    • Journal of Minimally Invasive Gynecology

    This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.